Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Oncologists
Technology Advances: CISH technology Facilitates Assay of HER2 Expression
Dorothy J. Schirf, MD, MDLinx Oncology
Today's Oncology News: VEGFb Designated Orphan Drug Status By FDA
D Scott Cunningham MD, PhD, MDLinx Oncology
  See all
breast cancer;breast conserving treatment Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Does the post-BCT local recurrence rate of only 5% to 10% indicate that radiation therapy may be unnecessary in many cases?
International Journal of Clinical Oncology, 05/19/08
Print     Email This Article     Save in My Library   Free Abstract
Ishida et al. – Preliminary results using 5 factors rather than 2 as criteria for post-breast-conserving treatment (BCT) irradiation appear promising and invite further investigation.

Methods
  • Local recurrence rates were examined in irradiated and nonirradiated pts who had undergone BCT, to investigate the question of RT appropriateness across groups
  • Pts were divided into 2 groups: a 2-factor group and a 5-factor group

Results
  • 85 pts were classified using only 2 factors (margin-positivity and lymphatic metastasis-positivity)
  • 318 pts were classified using 3 additional factors (lymphatic invasion, intraductal extension, and metachronous/synchronous bilateral br ca)
  • The use of 5 clinicopathological factors rather than 2 as the criteria for RT led to an increase in the irradiation ratio from 47.1% to 63.2% and a decrease in local recurrence from 12.9% to 2.2%
  • Investigators cautioned that this study was limited by the short average follow-up period and that randomized comparative studies are required, noting that patient age and margin condition as mandatory criteria for irradiation may also be necessary

 

Sponsor
--- BREAST TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.